Stem Cells from Healthy and Tendinopathic Human Tendons: Morphology, Collagen and Cytokines Expression and Their Response to T3 Thyroid Hormone

Cells. 2022 Aug 16;11(16):2545. doi: 10.3390/cells11162545.

Abstract

The aim of this study was to investigate the effect of triiodothyronine (T3) on tendon specific markers and cytokines expression of stem cells extracted from human tendons. Indeed, thyroid hormones have been reported to be protective factors, maintaining tendons' homeostasis, whereas tendinopathy is believed to be related to a failed healing response. Healthy and tendinopathic human tendons were harvested to isolate tendon stem/progenitor cells (TSPCs). TSPCs obtained from pathological samples showed gene expression and morphological modifications at baseline in comparison with cells harvested from healthy tissues. When cells were maintained in a medium supplemented with T3 (10-6 M), only pathological populations showed a significant upregulation of tenogenic markers (DCN, TNC, COL1A1, COL3A1). Immunostaining revealed that healthy cells constantly released type I collagen, typical of tendon matrix, whereas pathological ones overexpressed and secreted type III collagen, typical of scarred and impaired tissue. Pathological cells also overexpressed pro- and anti-inflammatory cytokines, suggesting an impaired balance in the presence of T3, without STAT3 activation. Moreover, DKK-1 was significantly high in the culture medium of pathological cell cultures and was reversed by T3. This study opens perspectives on the complex biochemical alteration of cells from pathological tendons, which may lead to the chronic disease context with an impaired extracellular matrix.

Keywords: T3 thyroid hormone; cytokines; tendinopathy; tendon stem/progenitor cells; type III collagen.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Achilles Tendon*
  • Collagen / metabolism
  • Cytokines / metabolism
  • Humans
  • Stem Cells
  • Triiodothyronine* / metabolism
  • Triiodothyronine* / pharmacology

Substances

  • Cytokines
  • Triiodothyronine
  • Collagen

Grants and funding

This research was funded by: (i) American Orthopedic Foot & Ankle Society (AOFAS) Research Committee, Grant ID#: 2019-133-S, Grant Project Title: “Nano-FT3C+: An Innovative Liposome-Based Formulation for Thyroid Hormone Controlled Delivery. An In Vitro Study on Tendinopathic Human Achilles Tendon Tenocytes”; (ii) Perspectives For Future Innovation in Tendon repair (P4 FIT) – European Union’s Horizon 2020 Research and Innovation Programme, part of H2020-MSCA-ITN-EJD programme, Grant ID#: 955685.